Ventyx Biosciences, Inc.

NasdaqGS:VTYX 주식 보고서

시가총액: US$130.8m

Ventyx Biosciences 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Raju Mohan

최고 경영자

US$9.4m

총 보상

CEO 급여 비율6.3%
CEO 임기6yrs
CEO 소유권2.4%
경영진 평균 재임 기간2yrs
이사회 평균 재임 기간3.5yrs

최근 관리 업데이트

Recent updates

We Think Ventyx Biosciences (NASDAQ:VTYX) Needs To Drive Business Growth Carefully

Nov 14
We Think Ventyx Biosciences (NASDAQ:VTYX) Needs To Drive Business Growth Carefully

Ventyx Biosciences: Ready To Escape "The Crash Cycle"

Nov 04

Is Ventyx Biosciences (NASDAQ:VTYX) In A Good Position To Invest In Growth?

Jul 12
Is Ventyx Biosciences (NASDAQ:VTYX) In A Good Position To Invest In Growth?

Ventyx Biosciences: Slim Chances In A Fat Market (Rating Downgrade)

Jul 01

Ventyx Pivots To Obesity Amid Transformation

Mar 12

Here's Why We're Watching Ventyx Biosciences' (NASDAQ:VTYX) Cash Burn Situation

Feb 15
Here's Why We're Watching Ventyx Biosciences' (NASDAQ:VTYX) Cash Burn Situation

Ventyx: Too Risky Right Now After Some Poor Data

Jan 18

Companies Like Ventyx Biosciences (NASDAQ:VTYX) Are In A Position To Invest In Growth

Sep 21
Companies Like Ventyx Biosciences (NASDAQ:VTYX) Are In A Position To Invest In Growth

Ventyx Biosciences (NASDAQ:VTYX) Is In A Good Position To Deliver On Growth Plans

Jun 07
Ventyx Biosciences (NASDAQ:VTYX) Is In A Good Position To Deliver On Growth Plans

We're Not Very Worried About Ventyx Biosciences' (NASDAQ:VTYX) Cash Burn Rate

Feb 20
We're Not Very Worried About Ventyx Biosciences' (NASDAQ:VTYX) Cash Burn Rate

Ventyx Biosciences: Not Chasing This Rally

Sep 18

We Think Ventyx Biosciences (NASDAQ:VTYX) Can Afford To Drive Business Growth

Aug 19
We Think Ventyx Biosciences (NASDAQ:VTYX) Can Afford To Drive Business Growth

Ventyx Biosciences GAAP EPS of -$0.39 beats by $0.06

Aug 15

Ventyx Biosciences autoimmune/autoinflammatory candidate meets phase 1 goals

Jun 29

We're Not Very Worried About Ventyx Biosciences' (NASDAQ:VTYX) Cash Burn Rate

May 06
We're Not Very Worried About Ventyx Biosciences' (NASDAQ:VTYX) Cash Burn Rate

We Think Ventyx Biosciences (NASDAQ:VTYX) Can Afford To Drive Business Growth

Jan 21
We Think Ventyx Biosciences (NASDAQ:VTYX) Can Afford To Drive Business Growth

CEO 보상 분석

Raju Mohan 의 보수는 Ventyx Biosciences 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

-US$153m

Jun 30 2024n/an/a

-US$171m

Mar 31 2024n/an/a

-US$193m

Dec 31 2023US$9mUS$596k

-US$193m

Sep 30 2023n/an/a

-US$181m

Jun 30 2023n/an/a

-US$158m

Mar 31 2023n/an/a

-US$125m

Dec 31 2022US$4mUS$567k

-US$108m

Sep 30 2022n/an/a

-US$91m

Jun 30 2022n/an/a

-US$73m

Mar 31 2022n/an/a

-US$69m

Dec 31 2021US$15mUS$423k

-US$85m

Sep 30 2021n/an/a

-US$84m

Jun 30 2021n/an/a

-US$79m

Mar 31 2021n/an/a

-US$65m

Dec 31 2020US$68kUS$37k

-US$28m

보상 대 시장: Raju 의 총 보상 ($USD 9.41M )은 US 시장( $USD 647.72K ).

보상과 수익: 회사가 수익성이 없는 동안 Raju 의 보상이 증가했습니다.


CEO

Raju Mohan (66 yo)

6yrs

테뉴어

US$9,411,949

보상

Dr. Raju S. Mohan, Ph.D. founded Ventyx Biosciences, Inc. in November 2018 and serves as its Chief Executive Officer and Director since then and serves as its President since November 22, 2023. Dr. Mohan h...


리더십 팀

이름위치테뉴어보상소유권
Sheila Gujrathi
Executive Chairperson3.5yrsUS$486.29k0%
$ 0
Raju Mohan
Founder6yrsUS$9.41m2.37%
$ 3.1m
John Nuss
Chief Scientific Officer5.8yrsUS$3.89m0.37%
$ 490.2k
Roy Gonzales
Interim Principal Financial Officer & Principal Accounting Officerless than a year데이터 없음0.0010%
$ 1.4k
Matthew Moore
Chief Operating Officerless than a year데이터 없음데이터 없음
Mark Forman
Chief Medical Officerless than a year데이터 없음데이터 없음

2.0yrs

평균 재임 기간

56yo

평균 연령

경험이 풍부한 관리: VTYX 의 관리팀은 경험 ( 2 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Sheila Gujrathi
Executive Chairperson3.5yrsUS$486.29k0%
$ 0
Raju Mohan
Founder6yrsUS$9.41m2.37%
$ 3.1m
Allison Hulme
Independent Director1.8yrsUS$834.42k0%
$ 0
Somasundaram Subramaniam
Independent Director6yrsUS$417.35k데이터 없음
Alexa Kimball
Member of Clinical & Scientific Advisory Boardno data데이터 없음데이터 없음
James Krueger
Member of Clinical & Scientific Advisory Boardno data데이터 없음데이터 없음
Bruce Sands
Member of Clinical & Scientific Advisory Boardno data데이터 없음데이터 없음
Emma Guttman-Yassky
Member of Clinical & Scientific Advisory Boardno data데이터 없음데이터 없음
William White
Independent Director3.5yrsUS$416.29k0%
$ 0
Onaiza Cadoret-Manier
Independent Director1.8yrsUS$837.34k0%
$ 0

3.5yrs

평균 재임 기간

60.5yo

평균 연령

경험이 풍부한 이사회: VTYX 의 이사회경험(평균 재직 기간 3.5 년)으로 간주됩니다.